Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis

Richard J. Allen(University of Leicester), Martin D. Tobin(University of Leicester), Justin M. Oldham(Michigan Medicine), Tasha E. Fingerlin(University of Colorado Denver), Simon P. Hart(University of Hull), Brian D. Hobbs(Brigham and Women's Hospital), John D. Newell(University of Iowa), Rebecca Braybrooke(National Institute for Health and Care Research), David C. Nickle(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ani Manichaikul(Human Genome Sciences (United States)), Ann Millar, Phuwanat Sakornsakolpat(Siriraj Hospital), Wim Timens(University Medical Center Groningen), Krina T. Zondervan(University of Oxford), Rachel K. Putman(Brigham and Women's Hospital), Eunice Oballa(GlaxoSmithKline (United Kingdom)), Helen Parfrey(University of Ulster), Don D. Sin(University of British Columbia), Helen Booth(University College London Hospitals NHS Foundation Trust), Dominic Furniss(Nuffield Orthopaedic Centre), Gauri Saini(Nottingham University Hospitals NHS Trust), Robin J. McAnulty(University College London), David J. Lederer(Regeneron (United States)), Nik Hirani(Edinburgh Royal Infirmary), María Molina‐Molina(Instituto de Salud Carlos III), Megan L. Paynton(University of Leicester), George O'connor(Boston University), Ian P. Hall(Nottingham Biomedical Research Centre), Richard Hubbard(Nottingham University Hospitals NHS Trust), Michael Ng(Nuffield Orthopaedic Centre), Hiroto Hatabu(Harvard University), Amy Dressen, Shwu‐Fan Ma(University of Chicago), Vidya Navaratnam(National Institute for Health and Care Research), Ma’en Obeidat(Nottingham Biomedical Research Centre), Moira K. B. Whyte(University of Edinburgh), Yohan Bossé(Institut universitaire de cardiologie et de pneumologie de Québec), Ian Sayers(University of Leicester), Beatriz Guillén‐Guío(Universidad de La Laguna), Gunnar Guðmundsson(University of Iceland), Luke M. Kraven(University of Leicester), Philippe Joubert(Institut universitaire de cardiologie et de pneumologie de Québec), Xuan Li(University of British Columbia), Andrew P. Morris(Manchester Academic Health Science Centre), Hanfei Xu(Boston University), Victor E. Ortega(Wake Forest University), Mike Hill(Nuffield Health), Vilmundur Guðnason(University of Iceland), Ke Hao(Icahn School of Medicine at Mount Sinai), William A. Fahy(GlaxoSmithKline (United Kingdom))
bioRxiv (Cold Spring Harbor Laboratory)
May 14, 2019
Cited by 31


Related Papers